Browsing by Author "Stanojevic, M. (57828665700)"
Now showing 1 - 6 of 6
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Failure to detect viral RNA in bat samples collected in the Balkan region(2016) ;Cirkovic, V. (7102074128) ;Stamenkovic, G. (6508293958) ;Jovanovic, J. (56911947600) ;Siljic, M. (55428134900) ;Paunovic, M. (36867077900)Stanojevic, M. (57828665700)Bats represent a known reservoir of emerging viruses, yet no molecular data are found about the occurrence of zoonotic viruses in bats in the Balkans. The aim of this study was to determine the presence of paramyxo- and hanta-viruses in bats, examined by PCR in 95 deceased bats, that were collected in Serbia and Montenegro, during the period 2002 to 2009. All samples tested positive for beta-actin mRNA, confirming successful RNA isolation and amplification. However, no sample tested positive for virus specific RNA. Our findings might reflect tissue degradation in carcass samples and do not exclude bats as potential viral reservoir in the surveyed geographic area. © 2016, Malaysian Society for Parasitology. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Failure to detect viral RNA in bat samples collected in the Balkan region(2016) ;Cirkovic, V. (7102074128) ;Stamenkovic, G. (6508293958) ;Jovanovic, J. (56911947600) ;Siljic, M. (55428134900) ;Paunovic, M. (36867077900)Stanojevic, M. (57828665700)Bats represent a known reservoir of emerging viruses, yet no molecular data are found about the occurrence of zoonotic viruses in bats in the Balkans. The aim of this study was to determine the presence of paramyxo- and hanta-viruses in bats, examined by PCR in 95 deceased bats, that were collected in Serbia and Montenegro, during the period 2002 to 2009. All samples tested positive for beta-actin mRNA, confirming successful RNA isolation and amplification. However, no sample tested positive for virus specific RNA. Our findings might reflect tissue degradation in carcass samples and do not exclude bats as potential viral reservoir in the surveyed geographic area. © 2016, Malaysian Society for Parasitology. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Genetic detection of Dobrava-Belgrade hantavirus in the edible dormouse (Glis glis) in central Serbia(2015) ;Stanojevic, M. (57828665700) ;Nikolic, V. (7102074128) ;Stajkovic, N. (6603334753) ;Stamenkovic, G. (6508293958) ;Bozovic, B. (57199353480) ;Cekanac, R. (6506792728) ;Marusic, P. (55859025000)Gligic, A. (6603811932)Hantaviruses are endemic in the Balkans, particularly in Serbia, where sporadic cases and/or outbreaks of hantaviral human disease have been reported repeatedly, and evidenced serologically. Here, we present genetic detection of Dobrava-Belgrade virus (DOBV) hantaviral sequences in wild rodents trapped in central Serbia. All the animals were pre-screened serologically by indirect immunofluorescence (IF) test and only those with a positive finding of hantaviral antigens were further tested by polymerase chain reaction. Of the total of 104 trapped animals, 20 were found to be IF positive and of those three were positive for hantaviral RNA: one Microtus arvalis for Tula virus, and one each of Apodemus agrarius and Glis glis for DOBV. Phylogenetic analysis of the obtained sequences implies putative DOBV spillover infection of A. agrarius and G. glis from Apodemus flavicollis. However, future investigations should help to identify the most common natural host and geographical distribution of DOBV in its reservoir hosts in Serbia. Copyright © Cambridge University Press 2014. - Some of the metrics are blocked by yourconsent settings
Publication Primary resistance to integrase strand-transfer inhibitors in Europe(2015) ;Casadellà, M. (55313615300) ;van Ham, P.M. (37078411200) ;Noguera-Julian, M. (55809082200) ;van Kessel, A. (56323841000) ;Pou, C. (37038216500) ;Hofstra, L.M. (56725273200) ;Santos, J.R. (57211058801) ;Garcia, F. (56094361600) ;Struck, D. (24448531300) ;Alexiev, I. (24400977400) ;Bakken Kran, A.M. (56899050900) ;Hoepelman, A.I. (26642864500) ;Kostrikis, Leontios G. (6701410435) ;Somogyi, S. (22938731900) ;Liitsola, K. (6602136869) ;Linka, M. (6603398285) ;Nielsen, C. (16407574900) ;Otelea, D. (16158062400) ;Paraskevis, D. (6603346862) ;Poljak, M. (55142297400) ;Puchhammer-Stöckl, E. (7004072273) ;Staneková, D. (55929730900) ;Stanojevic, M. (57828665700) ;Van Laethem, K. (55981159900) ;Zidovec Lepej, S. (56199694500) ;Clotet, B. (7102349252) ;Boucher, C.A.B. (47160966300) ;Paredes, R. (35410114800) ;Wensing, A.M.J. (6508292380) ;Sarcletti, M. (6701317878) ;Schmied, B. (25621923500) ;Geit, M. (19134329500) ;Balluch, G. (55442788400) ;Vandamme, A.M. (35380737400) ;Vercauteren, J. (23974986100) ;Derdelinckx, I. (6603307057) ;Sasse, A. (8707096300) ;Bogaert, M. (23988565100) ;Ceunen, H. (6506360798) ;De Roo, A. (7006802110) ;De Wit, S. (35398225800) ;Echahidi, F. (57202975401) ;Fransen, K. (7004958831) ;Goffard, J.C. (6506658107) ;Goubau, P. (7005101460) ;Goudeseune, E. (57193882829) ;Yombi, J.C. (59157647900) ;Lacor, P. (7004574261) ;Liesnard, C. (7003762110) ;Moutschen, M. (55410582100) ;Pierard, D. (7005362360) ;Rens, R. (23989386500) ;Schrooten, Y. (6507013158) ;Vaira, D. (57196877522) ;Vandekerckhove, L.P. (8522177300) ;Van den Heuvel, A. (23989847400) ;Van Der Gucht, B. (6505996172) ;Van Ranst, M. (7005113740) ;Van Wijngaerden, E. (7003282958) ;Vandercam, B. (18036201800) ;Vekemans, M. (7102935078) ;Verhofstede, C. (6701839343) ;Clumeck, N. (55666222200) ;Van Laethem, K. (57214766821) ;Beshkov, D. (6506548839) ;Alexiev, I. (57191071184) ;Begovac, J. (7004168039) ;Demetriades, I. (57202564459) ;Kousiappa, I. (26021286400) ;Demetriou, V. (57190110602) ;Hezka, J. (26633894500) ;Machala, L. (6602134360) ;Maly, M. (7006322760) ;Nielsen, C. (58145388800) ;Jørgensen, L.B. (59789814400) ;Gerstoft, J. (7005184715) ;Mathiesen, L. (7005240454) ;Pedersen, C. (59055533700) ;Nielsen, H. (56898475400) ;Laursen, A. (7005244428) ;Kvinesdal, B. (7003670848) ;Ristola, M. (6701816652) ;Suni, J. (7006140974) ;Sutinen, J. (55442803700) ;Hamouda, O. (6602677243) ;Kücherer, C. (15728217400) ;Berg, T. (15833772800) ;Braun, P. (15830994600) ;Poggensee, G. (6701801604) ;Däumer, M. (35866879300) ;Eberle, J. (7006490824) ;Heiken, H. (58248508900) ;Kaiser, R. (56898513600) ;Knechten, H. (6602690431) ;Korn, K. (57899379300) ;Müller, H. (56898382200) ;Neifer, S. (57154520100) ;Schmidt, B. (7402828561) ;Walter, H. (7201498954) ;Gunsenheimer-Bartmeyer, B. (55982834800) ;Harrer, T. (57195239184) ;Hatzakis, A. (35371482000) ;Magiorkinis, E. (6506531797) ;Hatzitheodorou, E. (8576410800) ;Haida, C. (15748135700) ;Zavitsanou, A. (24588345200) ;Magiorkinis, G. (13408749100) ;Lazanas, M. (57214859941) ;Chini, M. (57222331159) ;Magafas, N. (8576411800) ;Tsogas, N. (55321040300) ;Paparizos, V. (6603312670) ;Kourkounti, S. (24830656600) ;Antoniadou, A. (6602439504) ;Papadopoulos, A. (7101944704) ;Panagopoulos, P. (57188559280) ;Poulakou, G. (57202553879) ;Sakka, V. (24830860600) ;Chryssos, G. (8576412000) ;Drimis, S. (6508055603) ;Gargalianos, P. (56884347500) ;Lelekis, M. (57202568650) ;Chilomenos, G. (57202555160) ;Psichogiou, M. (57194563325) ;Daikos, G.L. (7005992826) ;Sabatakou, H. (57192175351) ;Panos, G. (14068983400) ;Haratsis, G. (8576412900) ;Kordossis, T. (7003771779) ;Kontos, A. (7004528694) ;Koratzanis, G. (6602389189) ;Theodoridou, M. (55410691500) ;Mostrou, G. (57202555333) ;Spoulou, V. (57195496297) ;Schmit, J.C. (7103116821) ;Hemmer, R. (7005513302) ;Arendt, V. (7004284060) ;Staub, T. (56992899600) ;Schneider, F. (57210277500) ;Roman, F. (57221356833) ;van de Vijver, D.A. (56898780500) ;van, P.H. (54789181900) ;Brinkman, K. (57203689423) ;Op de, Coul (57192174947) ;van der Ende, M.E. (35445430200) ;Hoepelman, I.M. (57202606575) ;van Kasteren, M. (6701859853) ;Juttmann, J. (7004560481) ;Kuipers, M. (56095250400) ;Langebeek, N. (6508032955) ;Richter, C. (7202686435) ;Santegoets, R.M. (55442820200) ;Schrijnders-Gudde, L. (55442835100) ;Schuurman, R. (56898703600) ;van de Ven, B.J. (55442795400) ;Åsjö, B. (7005985660) ;Bakken, Kran (57192175218) ;Ormaasen, V. (6603445217) ;Aavitsland, P. (7005933765) ;Paraschiv, S. (18438269500) ;Tudor, A.M. (55583649800) ;Jevtovic, D. (55410443900) ;Salemovic, D. (7801387340) ;Habekova, M. (6508159897) ;Mokras, M. (57034416800) ;Truska, P. (6507290776) ;Lunar, M. (23501935600) ;Babic, D. (57217747994) ;Tomazic, J. (6603749556) ;Vidmar, L. (6603633782) ;Vovko, T. (55571534800) ;Karner, P. (8897787600) ;Clotet, B. (35314248700) ;Garcia, F. (57202861929) ;Domingo, P. (7102960369) ;Galindo, M.J. (7006443943) ;Miralles, C. (57204250338) ;Del, Pozo (57473174000) ;Ribera, E. (57226412724) ;Iribarren, J.A. (7003397185) ;Ruiz, L. (7103184450) ;de la Torre, J. (56679235800) ;Vidal, F. (35517147900)Garcia, F. (58712834400)Objectives: The objective of this study was to define the natural genotypic variation of the HIV-1 integrase gene across Europe for epidemiological surveillance of integrase strand-transfer inhibitor (InSTI) resistance. Methods: This was a multicentre, cross-sectional study within the European SPREAD HIV resistance surveillance programme. A representative set of 300 samples was selected from 1950 naive HIV-positive subjects newly diagnosed in 2006-07. The prevalence of InSTI resistance was evaluated using quality-controlled baseline population sequencing of integrase. Signature raltegravir, elvitegravir and dolutegravir resistance mutations were defined according to the IAS-USA 2014 list. In addition, all integrase substitutions relative to HXB2 were identified, including those with a Stanford HIVdb score=10 to at least one InSTI. To rule out circulation of minority InSTIresistant HIV, 65 samples were selected for 454 integrase sequencing. Results: For the population sequencing analysis, 278 samples were retrieved and successfully analysed. No signature resistance mutations to any of the InSTIswere detected. Eleven (4%) subjects hadmutations at resistance-associated positions with an HIVdb score =10. Of the 56 samples successfully analysed with 454 sequencing, no InSTI signature mutationsweredetected, whereas integrase substitutionswithanHIVdbscore=10were found in8(14.3%) individuals. Conclusions:No signature InSTI-resistant variantswere circulating in Europe before the introduction of InSTIs. However, polymorphisms contributing to InSTI resistancewere not rare. As InSTI use becomes more widespread, continuous surveillance of primary InSTI resistance is warranted. These data will be key to modelling the kinetics of InSTI resistance transmission in Europe in the coming years. © The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Primary resistance to integrase strand-transfer inhibitors in Europe(2015) ;Casadellà, M. (55313615300) ;van Ham, P.M. (37078411200) ;Noguera-Julian, M. (55809082200) ;van Kessel, A. (56323841000) ;Pou, C. (37038216500) ;Hofstra, L.M. (56725273200) ;Santos, J.R. (57211058801) ;Garcia, F. (56094361600) ;Struck, D. (24448531300) ;Alexiev, I. (24400977400) ;Bakken Kran, A.M. (56899050900) ;Hoepelman, A.I. (26642864500) ;Kostrikis, Leontios G. (6701410435) ;Somogyi, S. (22938731900) ;Liitsola, K. (6602136869) ;Linka, M. (6603398285) ;Nielsen, C. (16407574900) ;Otelea, D. (16158062400) ;Paraskevis, D. (6603346862) ;Poljak, M. (55142297400) ;Puchhammer-Stöckl, E. (7004072273) ;Staneková, D. (55929730900) ;Stanojevic, M. (57828665700) ;Van Laethem, K. (55981159900) ;Zidovec Lepej, S. (56199694500) ;Clotet, B. (7102349252) ;Boucher, C.A.B. (47160966300) ;Paredes, R. (35410114800) ;Wensing, A.M.J. (6508292380) ;Sarcletti, M. (6701317878) ;Schmied, B. (25621923500) ;Geit, M. (19134329500) ;Balluch, G. (55442788400) ;Vandamme, A.M. (35380737400) ;Vercauteren, J. (23974986100) ;Derdelinckx, I. (6603307057) ;Sasse, A. (8707096300) ;Bogaert, M. (23988565100) ;Ceunen, H. (6506360798) ;De Roo, A. (7006802110) ;De Wit, S. (35398225800) ;Echahidi, F. (57202975401) ;Fransen, K. (7004958831) ;Goffard, J.C. (6506658107) ;Goubau, P. (7005101460) ;Goudeseune, E. (57193882829) ;Yombi, J.C. (59157647900) ;Lacor, P. (7004574261) ;Liesnard, C. (7003762110) ;Moutschen, M. (55410582100) ;Pierard, D. (7005362360) ;Rens, R. (23989386500) ;Schrooten, Y. (6507013158) ;Vaira, D. (57196877522) ;Vandekerckhove, L.P. (8522177300) ;Van den Heuvel, A. (23989847400) ;Van Der Gucht, B. (6505996172) ;Van Ranst, M. (7005113740) ;Van Wijngaerden, E. (7003282958) ;Vandercam, B. (18036201800) ;Vekemans, M. (7102935078) ;Verhofstede, C. (6701839343) ;Clumeck, N. (55666222200) ;Van Laethem, K. (57214766821) ;Beshkov, D. (6506548839) ;Alexiev, I. (57191071184) ;Begovac, J. (7004168039) ;Demetriades, I. (57202564459) ;Kousiappa, I. (26021286400) ;Demetriou, V. (57190110602) ;Hezka, J. (26633894500) ;Machala, L. (6602134360) ;Maly, M. (7006322760) ;Nielsen, C. (58145388800) ;Jørgensen, L.B. (59789814400) ;Gerstoft, J. (7005184715) ;Mathiesen, L. (7005240454) ;Pedersen, C. (59055533700) ;Nielsen, H. (56898475400) ;Laursen, A. (7005244428) ;Kvinesdal, B. (7003670848) ;Ristola, M. (6701816652) ;Suni, J. (7006140974) ;Sutinen, J. (55442803700) ;Hamouda, O. (6602677243) ;Kücherer, C. (15728217400) ;Berg, T. (15833772800) ;Braun, P. (15830994600) ;Poggensee, G. (6701801604) ;Däumer, M. (35866879300) ;Eberle, J. (7006490824) ;Heiken, H. (58248508900) ;Kaiser, R. (56898513600) ;Knechten, H. (6602690431) ;Korn, K. (57899379300) ;Müller, H. (56898382200) ;Neifer, S. (57154520100) ;Schmidt, B. (7402828561) ;Walter, H. (7201498954) ;Gunsenheimer-Bartmeyer, B. (55982834800) ;Harrer, T. (57195239184) ;Hatzakis, A. (35371482000) ;Magiorkinis, E. (6506531797) ;Hatzitheodorou, E. (8576410800) ;Haida, C. (15748135700) ;Zavitsanou, A. (24588345200) ;Magiorkinis, G. (13408749100) ;Lazanas, M. (57214859941) ;Chini, M. (57222331159) ;Magafas, N. (8576411800) ;Tsogas, N. (55321040300) ;Paparizos, V. (6603312670) ;Kourkounti, S. (24830656600) ;Antoniadou, A. (6602439504) ;Papadopoulos, A. (7101944704) ;Panagopoulos, P. (57188559280) ;Poulakou, G. (57202553879) ;Sakka, V. (24830860600) ;Chryssos, G. (8576412000) ;Drimis, S. (6508055603) ;Gargalianos, P. (56884347500) ;Lelekis, M. (57202568650) ;Chilomenos, G. (57202555160) ;Psichogiou, M. (57194563325) ;Daikos, G.L. (7005992826) ;Sabatakou, H. (57192175351) ;Panos, G. (14068983400) ;Haratsis, G. (8576412900) ;Kordossis, T. (7003771779) ;Kontos, A. (7004528694) ;Koratzanis, G. (6602389189) ;Theodoridou, M. (55410691500) ;Mostrou, G. (57202555333) ;Spoulou, V. (57195496297) ;Schmit, J.C. (7103116821) ;Hemmer, R. (7005513302) ;Arendt, V. (7004284060) ;Staub, T. (56992899600) ;Schneider, F. (57210277500) ;Roman, F. (57221356833) ;van de Vijver, D.A. (56898780500) ;van, P.H. (54789181900) ;Brinkman, K. (57203689423) ;Op de, Coul (57192174947) ;van der Ende, M.E. (35445430200) ;Hoepelman, I.M. (57202606575) ;van Kasteren, M. (6701859853) ;Juttmann, J. (7004560481) ;Kuipers, M. (56095250400) ;Langebeek, N. (6508032955) ;Richter, C. (7202686435) ;Santegoets, R.M. (55442820200) ;Schrijnders-Gudde, L. (55442835100) ;Schuurman, R. (56898703600) ;van de Ven, B.J. (55442795400) ;Åsjö, B. (7005985660) ;Bakken, Kran (57192175218) ;Ormaasen, V. (6603445217) ;Aavitsland, P. (7005933765) ;Paraschiv, S. (18438269500) ;Tudor, A.M. (55583649800) ;Jevtovic, D. (55410443900) ;Salemovic, D. (7801387340) ;Habekova, M. (6508159897) ;Mokras, M. (57034416800) ;Truska, P. (6507290776) ;Lunar, M. (23501935600) ;Babic, D. (57217747994) ;Tomazic, J. (6603749556) ;Vidmar, L. (6603633782) ;Vovko, T. (55571534800) ;Karner, P. (8897787600) ;Clotet, B. (35314248700) ;Garcia, F. (57202861929) ;Domingo, P. (7102960369) ;Galindo, M.J. (7006443943) ;Miralles, C. (57204250338) ;Del, Pozo (57473174000) ;Ribera, E. (57226412724) ;Iribarren, J.A. (7003397185) ;Ruiz, L. (7103184450) ;de la Torre, J. (56679235800) ;Vidal, F. (35517147900)Garcia, F. (58712834400)Objectives: The objective of this study was to define the natural genotypic variation of the HIV-1 integrase gene across Europe for epidemiological surveillance of integrase strand-transfer inhibitor (InSTI) resistance. Methods: This was a multicentre, cross-sectional study within the European SPREAD HIV resistance surveillance programme. A representative set of 300 samples was selected from 1950 naive HIV-positive subjects newly diagnosed in 2006-07. The prevalence of InSTI resistance was evaluated using quality-controlled baseline population sequencing of integrase. Signature raltegravir, elvitegravir and dolutegravir resistance mutations were defined according to the IAS-USA 2014 list. In addition, all integrase substitutions relative to HXB2 were identified, including those with a Stanford HIVdb score=10 to at least one InSTI. To rule out circulation of minority InSTIresistant HIV, 65 samples were selected for 454 integrase sequencing. Results: For the population sequencing analysis, 278 samples were retrieved and successfully analysed. No signature resistance mutations to any of the InSTIswere detected. Eleven (4%) subjects hadmutations at resistance-associated positions with an HIVdb score =10. Of the 56 samples successfully analysed with 454 sequencing, no InSTI signature mutationsweredetected, whereas integrase substitutionswithanHIVdbscore=10were found in8(14.3%) individuals. Conclusions:No signature InSTI-resistant variantswere circulating in Europe before the introduction of InSTIs. However, polymorphisms contributing to InSTI resistancewere not rare. As InSTI use becomes more widespread, continuous surveillance of primary InSTI resistance is warranted. These data will be key to modelling the kinetics of InSTI resistance transmission in Europe in the coming years. © The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Typing of macrolide resistant group A streptococci by random amplified polymorphic DNA analysis(2014) ;Gajic, I. (55428924700) ;Mijac, V. (6507998440) ;Stanojevic, M. (57828665700) ;Ranin, L. (6602522806) ;Smitran, A. (55865631000)Opavski, N. (6507364674)OBJECTIVE: Several studies of group A streptococci (GAS) have revealed that a small number of dominant resistant clones might be responsible for the spread of Streptococcus (S.) pyogenes resistance to macrolides. We aimed to determine the genetic diversity of macrolide resistant group A streptococci (MRGAS), isolated from patients with pharyngitis in Serbia.; MATERIALS AND METHODS: The clonal relationships among 76 MRGAS isolates collected during 2008 were studied using two molecular typing methods: emm typing and random amplified polymorphic DNA (RAPD) analysis. Isolates that share the same emm type and RAPD pattern were considered to belong to the same clone.; RESULTS: Out of 7 distinct emm types identified, the 3 most frequently occurring overall were emm12, emm75 and emm77 (> 90% of isolates). Although as many as 26 different RAPD patterns were found among the isolates studied, two clones with emm12 and emm77 accounted 32 out of 76 (42%) isolates.; CONCLUSIONS: The results indicate a polyclonal spread of erythromycin-resistant Streptococcus pyogenes in our country. Furthermore, predominance of two clones, particularly among emm12 and emm77 strains indicates that erythromycin-resistant GAS of the same clonal origin are widely distributed in Serbia.
